Boston, Massachusetts--(Newsfile Corp. - January 13, 2026) - Block & Leviton is investigating Apogee Enterprises, Inc. (NASDAQ: APOG) for potential securities law violations. Investors who have lost money in their Apogee Enterprises, Inc. investment should contact the firm to learn more about how they might recover those losses.

Biotech stock Travere Therapeutics Inc (NASDAQ:TVTX) is plummeting today, down 32.8% to trade at $22.92 at last glance, after news that the Food & Drug Administration (FDA) has new questions regarding its Filspari application, which could cause a potential delay for the serious kidney disease treatment.

President Trump's proposed 10% credit card interest rate cap could eliminate access for 175 million to 190 million cardholders, with lower and middle income consumers hit hardest.

ALB, KNOP and LINC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Jan.13, 2026.

NanoViricides (NYSE-A:NNVC), a clinical-stage company developing broad-spectrum antiviral drugs, has highlighted the current influenza season as an example of the need for antivirals capable of targeting multiple respiratory viruses. The US Centers for Disease Control and Prevention (CDC) has classified the 2025 to 2026 flu season as “moderately severe,” with the Influenza A/H3N2 subclade K responsible for more than 80% of cases.

Super Micro Computer Inc (NASDAQ:SMCI) shares are down 5.6% to trade at $28.44 at last glance, after Goldman Sachs initiated coverage with a "sell" rating and $26 price target, down from $34.

Paramount Skydance is taking another step in its hostile takeover bid of Warner Bros. Discovery, saying Monday that it will name its own slate of directors before the next shareholder meeting of the Hollywood studio.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 13, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company") on behalf of investors who purchased or otherwise acquired Jayud securities during the period of April 21, 2023 through April 30, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Jayud securities during the Class Period may, no later than January 20, 2026, seek to be appointed as a lead plaintiff representative of the class.

ANET's expanding switch portfolio, from 400G???800G data center platforms to rugged new launches, deepens its push into AI and cloud networking.

Applied Materials' NAND sales nearly double to $1.41 billion in FY25 as 3D NAND upgrades and new metrology tools boost its flash memory momentum.

Meta Platforms (NASDAQ: META) is reportedly laying off 10% of its Reality Labs workforce, highlighting the ongoing challenges within its metaverse division. While the segment has struggled with massive financial losses and stagnant adoption, Meta's strategic pivot toward AI has begun to reshape investor expectations.

SAN DIEGO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CoreWeave, Inc. (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”), have until March 13, 2026 to seek appointment as lead plaintiff of the CoreWeave class action lawsuit. Captioned Masaitis v.

Delta Air Lines Inc (NYSE:DAL) shares are down 2% to trade at $69.55, at last check.

JPMorgan's investment-banking fees unexpectedly fell in the fourth quarter, while the bank delivered results that otherwise mostly beat consensus. Dani Burger reports on Bloomberg Television.

EDEN PRAIRIE, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading manufacturer of premium outdoor recreation products, has published its 2025 Corporate Responsibility Report highlighting the company's commitment to responsible corporate citizenship and its advancements toward building a sustainable and inclusive future.

Morgan Stanley earnings set for Jan. 15, with strong trading and IB gains expected to lift Q4 revenue 6.8% year over year.

NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and cardiovascular risk reduction.

Solid Q4 earnings trends put sector ETFs in focus as growth broadens beyond Tech. ETFs ITA, XLK, VFH stand out.

Hancock Whitney (HWC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KeyCorp (KEY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.